Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Histology-based Consolidation Chemotherapy in Inoperable Stage III NSCLC
NCT01336543Phase 2Withdrawn
- Start
- Mar 2011
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed, gemcitabine in non-small cell lung cancer (NSCLC). Planned start Mar 2011; status: withdrawn.
02
Drugs
pemetrexedgemcitabine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01336543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01336543.